ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.276A>G (p.Pro92=)

gnomAD frequency: 0.14697  dbSNP: rs1800932
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 20
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
International Society for Gastrointestinal Hereditary Tumours (InSiGHT) RCV000030265 SCV000107992 no known pathogenicity Lynch syndrome 2013-09-05 reviewed by expert panel research MAF >1%
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000030265 SCV000052932 benign Lynch syndrome 2011-08-18 criteria provided, single submitter curation Converted during submission to Benign.
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000035321 SCV000058969 benign not specified 2011-07-22 criteria provided, single submitter clinical testing This variant is classified as benign because it does not result in an amino acid change and is common in the general population (rs1800932, MAF >1%).
Eurofins Ntd Llc (ga) RCV000035321 SCV000110152 benign not specified 2015-05-27 criteria provided, single submitter clinical testing
Ambry Genetics RCV000162362 SCV000212667 benign Hereditary cancer-predisposing syndrome 2014-10-24 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
PreventionGenetics, part of Exact Sciences RCV000035321 SCV000302873 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000616289 SCV000430948 benign Lynch syndrome 5 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Color Diagnostics, LLC DBA Color Health RCV000162362 SCV000537341 benign Hereditary cancer-predisposing syndrome 2015-03-30 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001711091 SCV000604271 benign not provided 2023-11-22 criteria provided, single submitter clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000616289 SCV000744285 benign Lynch syndrome 5 2015-09-21 criteria provided, single submitter clinical testing
Invitae RCV000755571 SCV000999957 benign Hereditary nonpolyposis colorectal neoplasms 2024-02-01 criteria provided, single submitter clinical testing
GeneDx RCV001711091 SCV001940724 benign not provided 2015-03-03 criteria provided, single submitter clinical testing
KCCC/NGS Laboratory, Kuwait Cancer Control Center RCV000616289 SCV004015975 benign Lynch syndrome 5 2023-07-07 criteria provided, single submitter clinical testing
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan RCV000035321 SCV004233649 benign not specified 2024-01-24 criteria provided, single submitter clinical testing This variant is classified as Benign based on local population frequency. This variant was detected in 31% of patients studied by a panel of primary immunodeficiencies. Number of patients: 29. Only high quality variants are reported.
Mayo Clinic Laboratories, Mayo Clinic RCV000035321 SCV000257228 benign not specified no assertion criteria provided clinical testing
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000616289 SCV000734207 benign Lynch syndrome 5 no assertion criteria provided clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000035321 SCV001552908 benign not specified no assertion criteria provided clinical testing #N/A
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute RCV000035321 SCV001906262 benign not specified no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000035321 SCV001918644 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000035321 SCV001958114 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.